Sprint Bioscience presents preclinical data from the DISA program at the research conference STING & TLR-Targeting Therapies Summit in Boston, USA, May 9 – 11, 2023. The conference is a specialized conference with participants from companies and academic groups that focus on research and drug development with the aim of blocking the ability of cancer cells to escape the immune response in the tumor. The conference covers everything from basic research to clinical trials and many present previously completely unpublished information. More about the meeting here.
